Immune-competent human skin disease models.

Area of Science:

• Dermatology
• Immunology
• Drug Discovery

Background:

• Skin diseases possess an inherent immune component.
• Existing animal models frequently fail in human drug development due to immunological disparities.
• There is a critical need for advanced in vitro methods that better reflect human immunology.

Purpose of the Study:

• To review progress in in vitro skin disease models that incorporate human immunology.
• To highlight the limitations of current models and propose future directions.
• To assess the potential of novel models for drug discovery and testing.

Main Methods:

• Review of existing literature on co-cultures and 3D organotypic skin models.
• Analysis of examples from skin fibrosis, autoimmune diseases, psoriasis, cancer, and contact allergy.
• Discussion of emerging technologies like organ-on-chip and induced pluripotent stem cells.

Main Results:

• Current in vitro models, including co-cultures and 3D organotypic models, show promise but are largely inadequate for accurately predicting drug efficacy.
• Significant immunological differences between animals and humans contribute to high failure rates in preclinical and clinical drug testing.
• Progress has been made in developing more human-relevant models, but substantial challenges remain.

Conclusions:

• Existing in vitro skin models are insufficient for reliable drug discovery and testing.
• Future developments in immune-competent skin-on-chip models utilizing induced pluripotent stem cells offer a promising next generation of research tools.
• These advanced models could significantly improve the success rate of dermatological drug development.